+AptekaEPIGEN
Pradaxa pack
Blood and haematology

Pradaxa — dabigatran etexilate, 150 mg, capsules, 30 pcs

Brand: Boehringer Ingelheim

€85Price per pack
+ delivery from €40

Pradaxa. Active ingredient: dabigatran etexilate, 150 mg. Dosage form: hard capsules with an opaque light blue cap and an opaque white body, size 0, containing yellowish granules, imprinted with the Boehringer Ingelheim logo and "R150". Pack size: 30 capsules of 150 mg.

Order via MAX
Original medicine Photo and video report Tracked delivery
SPECIFICATIONS

Key information

Active ingredientdabigatran etexilate
Strength150 mg
Dosage formHard capsules with an opaque light blue cap and an opaque white body, size 0, containing yellowish granules, imprinted with the Boehringer Ingelheim logo and "R150".
Pack size30 capsules of 150 mg
ABOUT THE MEDICINE

Full description

Pradaxa 150 mg is a prescription anticoagulant (direct thrombin inhibitor) from Boehringer Ingelheim for stroke prevention and the treatment of thromboembolic diseases in adults. • Active ingredient: dabigatran etexilate (as mesilate), 150 mg per capsule • Indications: prevention of stroke and systemic embolism in non-valvular atrial fibrillation with risk factors (standard dose 300 mg per day, 1 capsule of 150 mg twice daily); treatment and prevention of recurrence of deep vein thrombosis and pulmonary embolism • The capsule must not be opened or chewed, and its contents must not be emptied out — if the capsule is damaged, the bioavailability of dabigatran increases significantly, which raises the risk of bleeding • No special diet is required and the INR monitoring typical of vitamin K antagonists is usually not needed; however, kidney function should be assessed before starting and periodically during treatment • Contraindicated in severe renal impairment, active clinically significant bleeding, lesions at high risk of bleeding, prosthetic heart valves requiring anticoagulant therapy, and concomitant use of other anticoagulants (except when switching from one medicine to another) • The dose is reduced to 220 mg per day (110 mg capsules twice daily) in patients aged 80 and over and with concomitant verapamil; for patients aged 75–80 and those with moderate renal impairment, dose reduction is considered individually • Marketing authorisation holder: Boehringer Ingelheim International GmbH, Germany Description EN Pradaxa 150 mg is a prescription direct thrombin inhibitor (dabigatran etexilate mesylate) by Boehringer Ingelheim, used for stroke prevention in non-valvular atrial fibrillation (300 mg/day, one 150 mg capsule twice daily) and for treatment/prevention of recurrent DVT and pulmonary embolism in adults. The capsule must never be opened, chewed, or have its pellets removed, as this significantly increases dabigatran bioavailability and bleeding risk; renal function must be assessed before and periodically during treatment.

Administration

For oral use. The dosing regimen and duration of use are determined by the doctor, taking into account the official package leaflet.

Storage conditions

Store in the original package to protect from moisture (for the bottle: use within 4 months after opening and close tightly after each use). Keep out of the reach of children.

FAQ

Frequently asked questions

What active ingredient does Pradaxa contain?

Pradaxa contains dabigatran etexilate.

What dosage form is Pradaxa available in?

Dosage form: Hard capsules with an opaque light blue cap and an opaque white body, size 0, containing yellowish granules, imprinted with the Boehringer Ingelheim logo and "R150".. Strength: 150 mg.

How much medicine is in a Pradaxa pack?

The pack shown contains 30 capsules of 150 mg.

How should Pradaxa be stored?

Store in the original package to protect from moisture (for the bottle: use within 4 months after opening and close tightly after each use). Keep out of the reach of children.

How to order

Tap the button for your preferred messenger. A manager will check availability, confirm the price and ask for your full delivery address.

This information is for reference only. Consult a doctor and read the official package leaflet before use.